Home » Shop » hot sale » Preformed EPC Plain Liposomes with 45 mol% CHOL

Preformed EPC Plain Liposomes with 45 mol% CHOL

Original price was: $119.20.Current price is: $70.87.

Sale!
SKU: PW14836863287 Category:

Preformed EPC Plain Liposomes with 45 mol% CHOL

Catalog number: B2019459
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 5 mL
Molecular Weight or Concentration: N/A
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: RT
Keywords: Preformed EPC Plain Liposomes with 45 mol% CHOL
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Steenpass T, Lung A, Schubert R. Tresylated PEG-sterols for coupling of proteins to preformed plain or PEGylated liposomes Biochim Biophys Acta. 2006 Jan;1758(1):20-8.
  • Mahjoub MA, Dadashzadeh S, Haeri A, Shahhosseini S, Abbasian Z, Nowroozi F. Doxorubicin-Loaded Multivesicular Liposomes (DepoFoam) as a Sustained Release Carrier Intended for Locoregional Delivery in Cancer Treatment: Development, Characterization, and Cytotoxicity Evaluation Iran J Pharm Res. 2023 Feb 26;21(1):e134190.
  • Reinish LW, Bally MB, Loughrey HC, Cullis PR. Interactions of liposomes and platelets Thromb Haemost. 1988 Dec 22;60(3):518-23.
  • Lima AC, Reis RL, Ferreira H, Neves NM. Cellular Uptake of Three Different Nanoparticles in an Inflammatory Arthritis Scenario versus Normal Conditions Mol Pharm. 2021 Sep 6;18(9):3235-3246.
  • Immordino ML, Brusa P, Arpicco S, Stella B, Dosio F, Cattel L. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel J Control Release. 2003 Sep 4;91(3):417-29.
  • Ahmad I, Sarkar AK, Bachhawat BK. Effect of cholesterol in various liposomal compositions on the in vivo toxicity, therapeutic efficacy, and tissue distribution of amphotericin B Biotechnol Appl Biochem. 1990 Oct;12(5):550-6.
  • Farzaneh H, Ebrahimi Nik M, Mashreghi M, Saberi Z, Jaafari MR, Teymouri M. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy Int J Pharm. 2018 Nov 15;551(1-2):300-308.
  • Bally MB, Nayar R, Masin D, Cullis PR, Mayer LD. Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes Cancer Chemother Pharmacol. 1990;27(1):13-9.
  • Kashiwagi H, Ueno M. [Mechanism of micelle-vesicle transformation and control of vesicular sizes and properties] Yakugaku Zasshi. 2008 May;128(5):669-80.